https://research.manchester.ac.uk/en/publications/add-on-clinical-effects-of-simvastatin-and-ondansetron-in-patient/
Add-on clinical effects of simvastatin and ondansetron in patients with schizophrenia stabilized on...
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/00409-4755/
00409-4755 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8cea2f3a-cfa5-4a68-9ff4-b5a5a2085d08&type=display
These highlights do not include all the information needed to use ONDANSETRON INJECTION safely and...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e4766235-ac44-ca93-78a6-66d4ded33ada&audience=consumer
DailyMed - ONDANSETRON HYDROCHLORIDE tablet, film coated
ondansetron hydrochloridedailymedtabletfilmcoated
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=b38feff2-900a-4e0c-8260-8f090edbc0bc&type=display
ONDANSETRON
ondansetron
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=4df3a06e-4607-497f-b80f-80ad99f6a579&type=display
These highlights do not include all the information needed to use ONDANSETRON TABLETS safely and...
https://experts.arizona.edu/en/publications/an-open-label-dose-comparison-study-of-ondansetron-for-the-preven/
An open-label dose comparison study of ondansetron for the prevention of emesis associated with...
https://www.gov.uk/drug-safety-update/ondansetron-zofran-important-new-intravenous-dose-restriction
Ondansetron (Zofran): important new intravenous dose restriction - GOV.UK
New maximum single intravenous dose of ondansetron for the management of chemotherapy-induced nausea and vomiting (CINV) restricted due to risk of QTc...
ondansetronzofranimportantnewintravenous
https://nauseacareus.com/
Zofran (Ondansetron) US Guide 2026: ODT Dosage, Safety & Online Availability | Nausea Care US
Complete resource on Generic Zofran (Ondansetron) for nausea relief. Compare 4mg/8mg ODT prices, check interactions, and view express shipping options within...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f76d27c5-acd4-482c-e053-6294a90a5284&audience=consumer
DailyMed - ONDANSETRON HYDROCHLORIDE tablet, film coated
ondansetron hydrochloridedailymedtabletfilmcoated
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=4c74336c-11ec-420a-80e1-d8e4a8f1c46d&type=display
Ondansetron orally disintegrating tablets These highlights do not include all the information...
https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&query=Ondansetron&page=3&pagesize=20
DailyMed - Search Results for Ondansetron
search resultsdailymedondansetron
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c74336c-11ec-420a-80e1-d8e4a8f1c46d
DailyMed - ONDANSETRON tablet, orally disintegrating
dailymedondansetrontabletorally
https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&query=Ondansetron&page=2&pagesize=20
DailyMed - Search Results for Ondansetron
search resultsdailymedondansetron
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=93f6d82b-0594-4b48-9711-201d79a03315&audience=consumer
DailyMed - ONDANSETRON HYDROCHLORIDE tablet, film coated
ondansetron hydrochloridedailymedtabletfilmcoated
https://adisinsight.springer.com/drugsafety/803691128?error=cookies_not_supported&code=50925818-00e8-4e70-9547-71909a95ff39
Metoclopramide/ondansetron - AdisInsight
A 63-year-old woman developed an exacerbation of hypertensive crisis and type B1 lactic acidosis during treatment with metoclopramide for vomiting.
metoclopramideondansetronadisinsight
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ondansetron-hydrochloride
Definition of ondansetron hydrochloride - NCI Drug Dictionary - NCI
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes...
definition ofondansetron hydrochloridencidrugdictionary
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=e183c59c-2a7c-dba3-e053-2a95a90acf87&type=display
These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING...
https://adisinsight.springer.com/drugsafety/803565122?error=cookies_not_supported&code=e33b033a-fdb3-4b1d-ac2c-350026bfe8af
Ondansetron - AdisInsight
A 24-year-old woman developed reversible cerebral vasoconstriction syndrome (RCVS) during treatment with ondansetron for severe nausea and vomiting.The woman,
ondansetronadisinsight
https://seer.cancer.gov/oncologytoolbox/canmed/hcpcs/1403/
Q0179 Ondansetron - CanMED: HCPCS
CanMED: HCPCS. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronhcpcs
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/51662-1539/
51662-1539 ONDANSETRON - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/23155-0547/
23155-0547 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://www.vetpharm.uzh.ch/Wirkstoffe/000000009961/4025_01.html
Wirkstoff: Ondansetron - Chemie
CliniPharm Wirkstoffdaten: Wirk- und Inhaltsstoffe
wirkstoffondansetronchemie
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/55111-0153/
55111-0153 ONDANSETRON - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14752e63-c7a7-4400-825b-ddab1ab9e782&audience=consumer
DailyMed - ONDANSETRON tablet, orally disintegrating
dailymedondansetrontabletorally
https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ONDANSETRON+HYDROCHLORIDE&pagesize=20&page=3&audience=consumer
DailyMed - Search Results for ONDANSETRON HYDROCHLORIDE
search resultsdailymedondansetronhydrochloride
https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/ondansetron-marketed-zofran-information
Ondansetron (marketed as Zofran) Information | FDA
ondansetronmarketedzofraninformationfda
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/57237-0078/
57237-0078 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4df3a06e-4607-497f-b80f-80ad99f6a579&audience=professional
DailyMed - ONDANSETRON HYDROCHLORIDE tablet, film coated
ondansetron hydrochloridedailymedtabletfilmcoated
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=69017f9f-1815-46d2-8e40-71cad10fa9d1&type=display
PRESCRIBING INFORMATION ONDANSETRON ORALLY DISINTEGRATING TABLETS, USPRx only
prescribing informationondansetronorallytablets
https://www.semanticscholar.org/topic/Ondansetron-8-MG-Oral-Tablet/10700591
Ondansetron 8 MG Oral Tablet | Semantic Scholar
ondansetronmgoraltabletsemantic
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/55154-3680/
55154-3680 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/00904-6208/
00904-6208 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/63187-0709/
63187-0709 Ondansetron Hydrochloride - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetron hydrochloridendc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e57105a-b925-4182-9f70-d0fa0e613051&audience=consumer
DailyMed - ONDANSETRON HYDROCHLORIDE tablet, film coated
ondansetron hydrochloridedailymedtabletfilmcoated
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d763a30-c778-4560-82a0-91e7b99c8e85
DailyMed - ONDANSETRON tablet, orally disintegrating
dailymedondansetrontabletorally
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/68258-7068/
68258-7068 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/68788-9559/
68788-9559 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/63629-5083/
63629-5083 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/68071-3801/
68071-3801 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://pubmed.ncbi.nlm.nih.gov/24141698/?dopt=Abstract
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and...
Palonosetron is more effective than older 5HT3 RAs for controlling CINV in the delayed and overall postchemotherapy periods.
phase iiiclinical studies
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/70518-0892/
70518-0892 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9077873-ce47-8b7a-e053-2a95a90a64cb&audience=consumer
DailyMed - ONDANSETRON HYDROCHLORIDE tablet, film coated
ondansetron hydrochloridedailymedtabletfilmcoated
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/00179-0248/
00179-0248 Ondansetron Hydrochloride - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetron hydrochloridendc
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/51655-0008/
51655-0008 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://pmc.ncbi.nlm.nih.gov/articles/PMC11459287/
The Effect of Ondansetron on Improvement of Symptoms in Patients with Irritable Bowel Syndrome with...
Diarrhea-dominant irritable bowel syndrome (IBS-D) is a deliberating and chronic condition that can impair social activities. Determining proper medication...
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/55111-0154/
55111-0154 ONDANSETRON - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01d69f4d-eddf-4fc8-820b-832f11f2e3c0
These highlights do not include all the information needed to use ONDANSETRON INJECTION safely and...
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/00904-6552/
00904-6552 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/77651-1113/
77651-1113 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=72f29916-0f95-102d-e053-2991aa0aa5cd&audience=consumer
DailyMed - ONDANSETRON tablet, orally disintegrating
dailymedondansetrontabletorally
https://pubmed.ncbi.nlm.nih.gov/7513334/
Successful control of intractable nausea and vomiting requiring combined ondansetron and...
Chemically induced nausea and vomiting is a common symptom of advanced cancer effected through stimulation of dopamine (D2) or serotonin (5-HT3) receptors...
nausea and vomitingsuccessfulcontrolrequiringcombined
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/67877-0169/
67877-0169 Ondansetron - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ondansetronndc
https://boris-portal.unibe.ch/entities/publication/c99c9e04-ef97-4ae7-9eec-7ed31103dc2b
Enantioselective determination of ondansetron and 8-hydroxyondansetron in human plasma from...
A liquid chromatographic-mass spectrometric assay with atmospheric pressure chemical ionization for quantification of ondansetron and its main metabolite...
in humandeterminationondansetron
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2c94fed2-f880-44a9-8d10-93fa5713dcb4&audience=consumer
DailyMed - ONDANSETRON HYDROCHLORIDE tablet, film coated
ondansetron hydrochloridedailymedtabletfilmcoated
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e183c59c-2a7c-dba3-e053-2a95a90acf87&audience=consumer
DailyMed - ONDANSETRON tablet, orally disintegrating
dailymedondansetrontabletorally
https://publica.fraunhofer.de/entities/patent/ca7f4f59-9f26-4fca-9cea-e26350d8c69a
Ondansetron-Formen
US2004228689 A UPAB: 20060308 NOVELTY - A soil remediation system (30) comprises two soil treatment sites, heat sources in the two soil treatment sites, and...
ondansetronformen
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5fad6aba-321a-4ed3-8d8e-2806aaeb2ff7
These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING...
https://my.clevelandclinic.org/health/drugs/18321-ondansetron-tablets
Ondansetron Tablets
ondansetrontablets
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e5e8353f-4e4c-4036-9376-2ac205d13b14&audience=consumer
DailyMed - ONDANSETRON tablet, orally disintegrating
dailymedondansetrontabletorally